BMJ Neurology Open (Aug 2024)
3149 Real-world Australian experience with Ofatumumab in the MSBase registry
- Nevin John,
- Tomas Kalincik,
- Jeannette Lechner-Scott,
- Mark Slee,
- Suzanne Hodgkinson,
- Tim Spelman,
- Helmut Butzkueven,
- Michael Barnett,
- Allan Kermode,
- Richard Macdonell,
- Anneke Van Der Walt,
- Pamela McCombe,
- Marzena Fabis-Pedrini,
- William M Carroll,
- Margaret Migocki,
- Birte Schmitt
Affiliations
- Nevin John
- Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, London, UK
- Tomas Kalincik
- CORe, Department of Medicine, University of Melbourne, Parkville, Victoria, Australia
- Jeannette Lechner-Scott
- 27 University of Newcastle Hunter Medical Research Institute, Newcastle, New South Wales, Australia
- Mark Slee
- 9Liverpool Hospital, Sydney, NSW, Australia
- Suzanne Hodgkinson
- 9Liverpool Hospital, Liverpool, NSW, Australia
- Tim Spelman
- 5 Department of Health Services Research and Implementation Science, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
- Helmut Butzkueven
- Clinical Neurosciences, Alfred Health, Melbourne, Victoria, Australia
- Michael Barnett
- 1Royal Prince Alfred Hospital, Camperdown, NSW, Australia
- Allan Kermode
- 3Western Australian Neuroscience Research Institute, The University of Western Australia, Nedlands, WA, Australia
- Richard Macdonell
- Department of Neurology, Austin Health, Melbourne, Victoria, Australia
- Anneke Van Der Walt
- 3Department of Neurosciences, Monash University, Prahran, VIC, Australia
- Pamela McCombe
- 18Royal Brisbane and Women’s Hospital, Herston, QLD, Australia
- Marzena Fabis-Pedrini
- 3The Perron Institute for Neurological and Translational Science, The University of Western Australia, QEII Medical Centre, Nedlands, WA, Australia
- William M Carroll
- 1Centre for Neuromuscular and Neurological Disorders, Western Australian Neuroscience Research Institute, The University of Western Australia, Sir Charles Gairdner Hospital, QEII Medical Centre, Nedlands, Australia
- Margaret Migocki
- 1Novartis Pharmaceuticals Australia, Macquarie Park, NSW, Australia
- Birte Schmitt
- 1Novartis Pharmaceuticals Australia, Macquarie Park, NSW, Australia
- DOI
- https://doi.org/10.1136/bmjno-2024-ANZAN.127
- Journal volume & issue
-
Vol. 6,
no. Suppl 1
Abstract
No abstracts available.